MwanzoCYBN • NYSEAMERICAN
add
Cybin Inc
$ 6.99
Baada ya Saa za Kazi:(1.72%)+0.12
$ 7.11
Imefungwa: 25 Apr, 17:05:01 GMT -4 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 7.06
Bei za siku
$ 6.91 - $ 7.20
Bei za mwaka
$ 4.81 - $ 14.44
Wastani wa hisa zilizouzwa
elfu 260.03
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 31.33M | 15.94% |
Mapato halisi | -10.54M | 65.24% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.53 | 84.50% |
EBITDA | -31.28M | -16.41% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 136.29M | 249.47% |
Jumla ya mali | 253.55M | 95.45% |
Jumla ya dhima | 13.31M | 56.49% |
Jumla ya hisa | 240.24M | — |
hisa zilizosalia | 21.04M | — |
Uwiano wa bei na thamani | 0.59 | — |
Faida inayotokana na mali | -30.36% | — |
Faida inayotokana mtaji | -31.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -10.54M | 65.24% |
Pesa kutokana na shughuli | -27.12M | -4.15% |
Pesa kutokana na uwekezaji | elfu -303.00 | -104.06% |
Pesa kutokana na ufadhili | elfu -179.00 | -100.45% |
Mabadiliko halisi ya pesa taslimu | -18.03M | -186.34% |
Mtiririko huru wa pesa | -17.34M | -88.49% |
Kuhusu
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2019
Makao Makuu
Tovuti
Wafanyakazi
50
